state-of-the-art - urology - ucla
Post on 03-Feb-2022
3 Views
Preview:
TRANSCRIPT
The UCLA Frank Clark
Urology Center,
The Department of Urology,
and
The Office of Continuing
Medical Education,
David Geffen School of
Medicine at UCLA
UrologyS t a t e - o f - t h e - A r t
March 8-11, 2012
The Ritz-Carlton
Marina del Rey,
California
UrologyUCLAUCLA
S t a t e - o f - t h e -A r t
This course explores the most challenging management problems facing the practicing urologist. Distinguished faculty present current information and techniques in female urology, reconstructive surgery, overactive bladder, incontinence, management of renal stones, endourology, laparoscopy and robotics, urologic oncology (including kidney, prostate, bladder, and testis cancer), medical and surgical therapy for BPH, testosterone replacement therapy, erectile dysfunction, and pediatric urology. The conference emphasizes interaction between participants and faculty and allows ample time for case presentations and group discussions, ensuring an outstanding educational experience for attendees.
AT THE COMPLETION of this program, participants should be better able to:• Assess and correct various problems with incontinence, pelvic prolapse, voiding dysfunction,
and bladder pain in the adult• Manage prostate, kidney, bladder, and testis cancer• Evaluate and treat upper tract urinary calculi• Understand the present role of laparoscopic, robotic, and minimally invasive surgery in urology• Assess and treat a variety of pediatric urologic conditions• Understand the latest developments in the management of BPH, erectile dysfunction, and
andrology
Participants will be provided a hands-on experience on two robot consoles with simulators throughout the conference until 1pm Sunday.
UCLA
S t a t e - o f - t h e - A r t
Urology
Course ChairWilliam J. Aronson, MD
Conference CoordinatorAnna-Lisa Nilsson
D e p a r t m e n t o f U r o l o g y F a c u l t y *
Mark S. Litwin, MD, MPHProfessor and ChairDepartment of UrologyProfessor of Health ServicesSchool of Public Health
William J. Aronson, MDChad Baxter, MDArie S. Belldegrun, MDCarol J. Bennett, MDArnold I. Chin, MD, PhD Bernard M. Churchill, MDJean B. deKernion, MD Steven E. Lerman, MDLeonard S. Marks, MDAllan J. Pantuck, MD, MSJacob Rajfer, MDShlomo Raz, MDRobert E. Reiter, MD, MBALarissa V. Rodríguez, MDChristopher S. Saigal, MD, MPHJennifer S. Singer, MDRobert B. Smith, MD
U C L A F a c u l t y *
Alexander Ernest, MD Visiting Professor
Fairooz F. Kabbinavar, MDProfessorDepartment of MedicineDivision of Hematology & Oncology
Christopher R. King, MD, PhDAssociate ProfessorDepartment of Radiation Oncology
Patrick A. Kupelian, MDProfessor and Vice Chair Department of Radiation Oncology
Steven S. Raman, MDAssociate Clinical Professor of
Radiology Department of Radiology
Matthew Rettig, MDAssociate ProfessorDepartment of MedicineDivision of Hematology & OncologyDepartment of Urology
Jonathan Said, MD Professor and Chief of Anatomic
Pathology
G u e s t F a c u l t y
Gennady Bratslavsky, MDProfessor and Chairman, Department
of UrologySUNY Upstate Medical UniversitySyracuse, New York
Laurence Klotz, MDProfessor of Surgery, University of
TorontoSunnybrook Health Sciences Centre Toronto, OntarioCanada
Kathleen C. Kobashi, MDHead, Section of Urology and Renal
TransplantationVirginia Mason Medical CenterSeattle, Washington
Kevin T. McVary, MDProfessor of Urology Feinberg School of Medicine Northwestern University Chicago, Illinois
Mark S. Soloway, MDProfessor, Department of Urology University of Miami Miller School of
Medicine Miami, Florida
Michael Stifelman, MDAssociate Professor Urology, NYU
School of Medicine Director, Robotic Surgery Center NYU
Langone Medical CenterChief of Service, Department of
Urology, Tisch Hospital ServiceNew York, New York
Nicholas J. Vogelzang, MD Chair and Medical Director Developmental Therapeutics
Committee US Oncology Research Vice-Chair SWOG GU Committee Comprehensive Cancer CenterLas Vegas, Nevada
*David Geffen School of Medicine at UCLA
F A C U L T Y
T H U R S D A Y , M A R C H 8 , 2 0 1 2
3:00-7:00 PM REGISTRATION FOR ROBOTIC SIMULATION DRY LAB AND GENERAL SESSION
4:00-8:00 PM Robotic Simulation Lab – $100 (limited to 20 participants) Two Robot Consoles with Simulators
4:00-4:45PM Robotic Prostatectomy, Robotic Partial Nephrectomy Surgical Aspects, New Technologies and Surgical Tools Maximizing Autonomy
Robert E. Reiter, MD, MBA; Michael Stifelman, MD 4:45-8:00PM Robotic Prostatectomy/Partial Nephrectomy Dry Lab Robert E. Reiter, MD, MBA; Michael Stifelman, MD
M O R N I N G 7:00 REGISTRATION / BREAKFAST /
EXHIBITS 7:50 Introductions and Announcements William J. Aronson, MD
F e m a l e U r o l o g y , S t r e s s I n c o n t i n e n c e V o i d i n g D y s f u n c t i o n , R e c o n s t r u c t i o n
Moderator: Shlomo Raz, MDSlingathon: What is the Best Sling for Which Patient 8:00 Obturator and Single Incision
Slings Kathleen C. Kobashi, MD 8:20 Retropubic Slings: TVT, Sparc,
Distal Urethral Prolene Sling Larissa V. Rodriguez, MD 8:40 Spiral and Fascial Slings Chad Baxter, MD 8:55 Managing and Avoiding
Complications of Sling Procedures Shlomo Raz, MD 9:20 BREAK / EXHIBITS 9:40 Refractory Overactive Bladder:
Point Counter-Point Should We Stimulate or Paralyze the Nerves
Paralyze – Botox Kathleen C. Kobashi, MD Stimulate – Neuromodulation Shlomo Raz, MD 10:00 Bladder/Pelvic Pain Evaluation
and Management State-of-the-Art
Kathleen C. Kobashi, MD 10:20 Treatment of Vault Prolapse Robotic vs. Vaginal Approach Chad Baxter, MD, Kathleen C.
Kobashi, MD, Shlomo Raz, MD, Larissa V. Rodriguez, MD
10:50 Case Presentations and Panel Discussion
Moderator: Dr Larissa V. Rodriguez Panel: Drs Baxter, Kobashi, Raz 12:00 LUNCH WITH FACULTY
A F T E R N O O N
K i d n e y C a n c e r , M a n a g e m e n t o f S m a l l R e n a l M a s s e s a n d A d v a n c e d D i s e a s e
Moderator: Arie S. Belldegrun, MD 1:10 What’s New in 2012 in Kidney
Cancer? Arie S. Belldegrun, MD 1:20 Active Surveillance Role for Needle Biopsy Allan J. Pantuck, MD, MS 1:30 Ablation (RFA, Cryo) Pro – Steven S. Raman, MD Con – Gennady Bratslavsky, MD 1:50 Nephron Sparing Surgery Robotic/Laparoscopic vs. Open Gennady Bratslavsky, MD,
Arie S. Belldegrun, MD 2:10 Robotic Kidney Surgery Tips and Tricks Michael Stifelman, MD,
Gennady Bratslavsky, MD 2:30 BREAK / EXHIBITS 2:50 Advanced Kidney Cancer
Role of the Surgeon Fairooz F. Kabbinavar, MD,
Nicholas J. Vogelzang, MD
C a s e P r e s e n t a t i o n s w i t h F a c u l t y P a r t i c i p a t i o n
3:10 65 yo with incidental 1.5cm tumor Biopsy, Ablate, Observe, Partial?
3:20 68 yo with 4cm peripheral anterior tumor
F R I D A Y , M A R C H 9 , 2 0 1 2
c c c
6:30 BREAKFAST / EXHIBITS
V I D E O S E S S I O N
7:00 Pelvic Reconstructive Surgery, Fistula, Sling, Prolapse, Artificial Sphincter Revision
Shlomo Raz, MD
P r o s t a t e C a n c e r
Moderator: Jean B. deKernion, MD 8:00 Tumor Markers in Clinical
Practice Leonard S. Marks, MD 8:10 Active Surveillance – Rationale,
Results, and Future Directions Laurence Klotz, MD 8:30 MRI to Improve Prostate Cancer
Detection and Guide Surgical Therapy
Robert E. Reiter, MD, MBA 8:50 Positive Surgical Margins After
Radical Prostatectomy Treat or not to treat
Mark S. Soloway, MD 9:05 Stereotactic Body Radiation
Therapy (SBRT) Ready For Prime Time?
Christopher R. King, MD, PhD 9:20 BREAK/EXHIBITS 9:40 Intermittent Androgen
Deprivation Application to Clinical Practice
Laurence Klotz, MD 10:00 Case Study: 66 yo with
Intermediate-Risk Prostate Cancer GG 3+4 in 30% of 1 core, 5% Gleason 4 pattern, PSA 6.5, prostate volume 35cc
Therapy Mark S. Litwin, MD, MPH Active Surveillance Laurence Klotz, MD
10:20 Update on Focal, Primary and Salvage Cryotherapy
Arie S. Belldegrun, MD10:30 Advanced Prostate Cancer Case
Studies – Applying the New and Old Therapies
Nicholas J. Vogelzang, MD10:50 Panel Discussion and Case
Presentations Late Breaking News – New Targeted Therapies
Moderator: Dr Jean B. deKernion Panel: Drs Belldegrun, King, Klotz,
Litwin, Marks, Reiter, Rettig, Soloway, Vogelzang
12:10 LUNCH WITH FACULTY
A F T E R N O O N
B l a d d e r C a n c e r , T e s t i c u l a r C a n c e r
Moderator: Robert B. Smith, MD 1:20 Non-Muscle-Invasive Bladder
Cancer Updated Guidelines
Arnold I. Chin, MD, PhD 1:40 Difficult Decisions in Bladder
Cancer – Case Studies With The Panel
Mark S. Soloway, MD 2:20 Contemporary Management of
Patients with Testicular Cancer Mark S. Litwin, MD, MPH 2:40 Panel Discussion and Case
Presentations Moderator: Dr Robert B. Smith Panel: Drs Chin, Kupelian, Litwin,
Soloway, Vogelzang 3:10 BREAK / EXHIBITS
S A T U R D A Y , M A R C H 1 0 , 2 0 1 2
3:30 71 yo with a 5 cm deep endophytic mass Imaging, Partial, Open vs Lap/Robot
3:40 60 yo with a large renal mass, bilateral pulmonary nodules Nephrectomy? Systemic Therapies
3:50 59 yo with 12 cm renal mass and 2cm lymph node Lymph Node Dissection?
4:00 Panel Discussion Moderator: Dr Arie S. Belldegrun Panel: Drs Bratslavsky, Kabbinavar,
Pantuck, Raman, Said, Smith, Stifelman, Vogelzang
5:30 ADJOURN 5:30 RECEPTION
F R I D A Y , M A R C H 9 , 2 0 1 2 ( C O N T I N U E D )
S U N D A Y , M A R C H 1 1 , 2 0 1 2
M O R N I N G 6:30 BREAKFAST / EXHIBITS
V I D E O S E S S I O N
7:00 Robotic Cystectomy Laparoscopy and Endourology Arnold I. Chin, MD, PhD,
Alexander Ernest, MD
P e d i a t r i c U r o l o g y
Moderator: Jennifer S. Singer, MD 8:00 What’s New in Pediatric Urology? Bernard M. Churchill, MD Steven E. Lerman, MD 8:40 Panel Discussion and Case
Presentations Moderator: Dr Jennifer S. Singer Panel: Drs Churchill, Lerman 9:10 BREAK / EXHIBITS
P e n i l e R e h a b i l i t a t i o n , A n d r o l o g y , I n f e r t i l i t y , H i s t o r y o f U r o l o g y
Moderator: Carol J. Bennett, MD 9:30 Tailored Approaches for Penile
Rehabilitation Therapy Kevin T. McVary, MD 9:50 Evaluation and Treatment of
Oligospermia Jacob Rajfer, MD 10:10 Androgen Replacement Therapy State-of-the-Art Kevin T. McVary, MD 10:30 Who’s Who in Urology A Brief History of Urology Mark S. Soloway, MD 11:00 Panel Discussion and Case
Presentations Moderator: Dr Carol J. Bennett Panel: Drs McVary, Rajfer, Soloway 12:00 ADJOURN
View from the Ritz-Carlton, Marina del Rey
BPH Medica l /Surgica l Therapy, S tones , Robot ic Urinary Reconstruct ion
Moderator: Christopher S. Saigal, MD, MPH 3:30 BPH – State-of-the-Art Medical and Surgical Therapies PDE-5 Inhibitors Kevin T. McVary, MD 4:00 Ureteroscopy, Nephroscopy for
Renal stones Tips and Tricks
Alexander Ernest, MD
4:20 Robotic Urinary Reconstruction Michael Stifelman, MD 4:40 Panel Discussion and Case
Presentations Moderator: Dr Christopher S. Saigal Panel: Drs Ernest, McVary,
Stifelman 5:15 ADJOURN
S A T U R D A Y , M A R C H 1 0 , 2 0 1 2 ( C O N T I N U E D )
E n r o l l m E n t F E E s
(Fees include course registration and materials, daily continental breakfasts and breaks, Friday evening reception, and Friday and Saturday luncheons.)$550.00 physicians$275.00 non-physician, healthcare professionals$110.00 residents (accompanied by a confirmatory
letter of status from department chief or training director)
A c c r E d i t A t i o n
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 20 (plus 4 for Dry Lab) AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
d i s c l o s u r E
The FDA has issued a concept paper that classifies the commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is truly independent and free of commercial influence. Along with independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the Continuing Medical Education staff and faculty be fully disclosed to the program’s participants. In addition, ACCME policy now mandates that the sponsor adequately manage all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
The Department of Urology is a California Board of Nursing approved provider (#8888).
l o c A t i o n
The Ritz-Carlton, Marina del Rey4375 Admiralty WayMarina del Rey, California 90292310-823-1700 or 800-241-3333310-823-2404 facsimilewww.ritzcarlton.com/hotels/marina_del_rey
March is the ideal time of year to visit Southern California. Temperatures are usually in the mid 70s, and skies are sunny and clear. The Ritz-Carlton overlooks the world’s largest small craft harbor and offers spectacular coastline vistas from the balcony of every guestroom. Guests will enjoy two lighted tennis courts, a waterfront swimming pool and state-of-the-art fitness center/spa, as well as other amenities that give the Ritz-Carlton its uncompromising reputation.
Within walking distance of the hotel are a variety of restaurants, clubs, and shops, as well as biking paths, jogging trails and, of course, the Marina Beach. Close by are art galleries, popular restaurants, architectural showpieces, and the distinctive cultural scenes of Santa Monica and Venice Beach. Shopping in Beverly Hills, Century City, and Santa Monica’s 3rd Street Promenade is close by. The Los Angeles area offers a variety of vacation entertainment for both adults and children. Disneyland, Knott’s Berry Farm, Six Flags Magic Mountain, and Universal Studios are just a few of the attractions that help make a visit to Southern California a memorable experience.
A c c o m m o d A t i o n s
A block of rooms has been reserved at the Ritz-Carlton for conference participants at a special conference rate of $270.00 plus tax per night for single/double occupancy. One night’s deposit is required to guarantee late arrival (after 5pm). Confirmation of reservations received after February 7, 2012, is subject to availability.
For reservations call 310-823-1700 or 800-241-3333. Be sure to mention UCLA’s State-of-the-Art Urology Conference when calling in your reservations.
P A r k i n g
Daytime: $10 valet only Overnight: $25
E m E r g E n c y c A l l s
You may be reached during the conference at 310-823-1700. Ask the hotel operator to direct your call to the UCLA State-of-the-Art Urology conference registration desk.
t r A n s P o r t A t i o n t o H o t E l F r o m l A X
Taxi or shuttle service is available from Los Angeles International Airport to the Ritz-Carlton, Marina del Rey.
r E F u n d s
Cancellations must be received in writing by February 7, 2012, and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. You may fax your refund request to 310-794-2624.
G E N E R A L I N F O R M A T I O N
Please visit our websites: www.uclaurology.com and www.cme.ucla.edu
E n r o l l m E n t
OnlineUse your American Express, MasterCard, Visa, or Discover card.www.cme.ucla.edu/courses Click on “UCLA State-of-the-Art Urology.”By MailUse the form attached. For additional applications, use a photocopy or separate sheet giving all information requested on the form.By PhoneUse MasterCard, Visa, or Discover.Call 310-794-2620
By FAXSend the completed enrollment form with charge card information and authorizing signature to the Office of Continuing Medical Education at 310-794-2624.
ENROLLMENT IS LIMITED. EARLY ENROLLMENT IS ADVISED.
For additional information, contact the Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, Urology Conference, 10920 Wilshire Boulevard, Suite 1060, Los Angeles, CA 90024-6512; 310-794-2620; E-Mail address: eayala@mednet.ucla.edu.
REGISTRATION FORM
Winter 2012
Social Security Number (last four digits only)
Name (First/Middle/Last) q Male q Female Degree (MD, PhD, RN, NP, etc.)
Preferred Mailing Address
City/State/ZIP
Area Code/Daytime Phone Fax
E-mail address
Field of Practice
q Check enclosed payable to: The Regents of the University of California
Charge: q MasterCard q Visa q Discover
__________________________ – __________________________ – __________________________ – ___________
Authorizing Signature Expiration Date
Mail to: Office of Continuing Medical Education, Urology, David Geffen School of Medicine at UCLA, 10920 Wilshire Blvd., Suite 1060, Los Angeles, CA 90024-6512.
Fax to: 310-794-2624
Fee
UCLA State-of-the-Art Urology M112-28 $
Dry Lab (limit 20) $
Total $
$100.00 Dry Lab Fee (must be in conjunction with general session)
General Session Fee $550.00 physicians $275.00 non-physicians, healthcare professionals $110.00 residents (accompanied by a confirmatory
letter of status from department chief or training director)Please Print
"
UC
LA O
ffiC
e O
f C
On
tin
Uin
g M
ed
iCA
L e
dU
CA
tiO
n
dA
vid
ge
ffe
n S
Ch
OO
L O
f M
ed
iCin
e A
t U
CLA
M
C29
405
hiL
gA
rd
Av
en
Ue
BO
x 9
5693
8LO
S A
ng
eLe
S, C
A 9
0095
-693
8
nO
npr
Ofi
t O
rg
.U
.S. p
OSt
Ag
e
pAid
UC
LA
Stat
e-of
-the
-Art
Urolo
gyM
arch
8-1
1, 2
012
The
Rit
z-C
arlto
n
Mar
ina
del R
ey, C
alifo
rnia
UC
LA
top related